Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia

Neoplasia

Volumn 11, Issue 6, 2009, Pages 542-551

  Nitin, Nitin ^a   Rosbach, Kelsey J ^b   El Naggar, Adel ^c   Williams, Michelle ^c   Gillenwaterand, Ann ^c   Richards Kortum, Rebecca R ^b,d  

^a SOUTHWEST RESEARCH INSTITUTE   (United States)

^b RICE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; EPIDERMAL GROWTH FACTOR ALEXA 647 CONJUGATE; EPIDERMAL GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MOLECULAR IMAGING; MOUTH CANCER; MOUTH MUCOSA; ORAL BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE CULTURE;

EID: 66449088610     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09188     Document Type: Article

References (49)

1. Gelovani Tjuvajev J and Blasberg RG (2003). In vivo imaging of moleculargenetic targets for cancer therapy. Cancer Cell 3, 327-332.
2. Massoud TF and Gambhir SS (2007). Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med 13, 183-191. (Pubitemid 46687127)
3. Pomper MG (2005). Translational molecular imaging for cancer. Cancer Imaging 5 Spec No A, S16-S26.
4. Sokolov K, Aaron J, Hsu B, Nida D, Gillenwater A, Follen M, MacAulay C, Adler-Storthz K, Korgel B, Descour M, et al. (2003). Optical systems for in vivo molecular imaging of cancer. Technol Cancer Res Treat 2, 491-504. (Pubitemid 38040612)
5. Weissleder R (2006). Molecular imaging in cancer. Science 312, 1168-1171. (Pubitemid 43801133)
6. Bankfalvi A and Piffko J (2000). Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med 29, 291-298. (Pubitemid 30459299)
7. Chimenos-Kustner E, Font-Costa I, and Lopez-Lopez J (2004). Oral cancer risk and molecular markers. Med Oral Patol Oral Cir Bucal 9, 381-384; 377-380.
8. Macluskey M and Ogden GR (2000). An overview of the prevention of oral cancer and diagnostic markers of malignant change: 2. Markers of value in tumour diagnosis. Dent Update 27, 148-152.
9. Schliephake H (2003). Prognostic relevance of molecular markers of oral cancer- a review. Int J Oral Maxillofac Surg 32, 233-245. (Pubitemid 36700729)
10. Banerjee AG, Bhattacharyya I, and Vishwanatha JK (2005). Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol Cancer Ther 4, 865-875. (Pubitemid 40909069)
11. Braakhuis BJ, Leemans CR, and Brakenhoff RH (2004). A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 33, 317-322. (Pubitemid 38931752)
12. Lippman SM, Sudbo J, and Hong WK (2005). Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23, 346-356. (Pubitemid 46206883)
13. Mankoff DA, Shields AF, and Krohn KA (2005). PET imaging of cellular proliferation. Radiol Clin North Am 43, 153-167. (Pubitemid 40326566)
14. Muzi M, Mankoff DA, Grierson JR, Wells JM, Vesselle H, and Krohn KA (2005). Kinetic modeling of 3′-deoxy-3′-fluorothymidine in somatic tumors: mathematical studies. J Nucl Med 46, 371-380. (Pubitemid 43073449)
15. Stokkel MP, ten Broek FW, and van Rijk PP (1998). The role of FDG PET in the clinical management of head and neck cancer. Oral Oncol 34, 466-471. (Pubitemid 28546859)
16. Onizawa K, Saginoya H, Furuya Y, Yoshida H, and Fukuda H (1999). Usefulness of fluorescence photography for diagnosis of oral cancer. Int J Oral Maxillofac Surg 28, 206-210.
17. Onizawa K, Okamura N, Saginoya H, and Yoshida H (2003). Characterization of autofluorescence in oral squamous cell carcinoma. Oral Oncol 39, 150-156. (Pubitemid 36050920)
18. Betz CS, Stepp H, Janda P, Arbogast S, Grevers G, Baumgartner R, and Leunig A (2002). A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer 97, 245-252. (Pubitemid 34019962)
19. Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, and Baumgartner R (2000). Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope 110, 78-83. (Pubitemid 30046650)
20. McLoone N, Donnelly RF, Walsh M, Dolan OM, McLoone S, McKenna K, and McCarron PA (2008). Aminolaevulinic acid diffusion characteristics in "in vitro" normal human skin and actinic keratosis: implications for topical photodynamic therapy. Photodermatol Photoimmunol Photomed 24, 183-190.
21. Frangioni JV (2006). Translating in vivo diagnostics into clinical reality. Nat Biotechnol 24, 909-913. (Pubitemid 44215378)
22. Rumboldt Z, Day TA, and Michel M (2006). Imaging of oral cavity cancer. Oral Oncol 42, 854-865. (Pubitemid 44428224)
23. Simon LL and Rubinstein D (2006). Imaging of oral cancer. Otolaryngol Clin North Am 39, 307-317; vi.
24. Wilder-Smith P, Krasieva T, Jung WG, Zhang J, Chen Z, Osann K, and Tromberg B (2005). Noninvasive imaging of oral premalignancy and malignancy. J Biomed Opt 10, 051601. (Pubitemid 44256006)
25. Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman RC, Ravanpay AC, Stroud MR, Kusuma Y, Hansen SJ, et al. (2007). Tumor paint: a chlorotoxin: Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67, 6882-6888.
26. Ekberg T, Nestor M, Engstrom M, Nordgren H, Wester K, Carlsson J, and Anniko M (2005). Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue. Int J Oncol 26, 1177-1185.
27. Kuttan NA and Bhakthan NM (1997). Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: overexpression, localization and therapeutic implications. Indian J Dent Res 8, 9-18.
28. Richter P, Bohmer FD, Hindermann W, Borsi L, Hyckel P, Schleier P, Katenkamp D, Kosmehl H, and Berndt A (2005). Analysis of activated EGFR signalling pathways and their relation to laminin-5 gamma2 chain expression in oral squamous cell carcinoma (OSCC). Histochem Cell Biol 124, 151-160. (Pubitemid 41429770)
29. Todd R and Wong DT (1999). Epidermal growth factor receptor (EGFR) biology and human oral cancer. Histol Histopathol 14, 491-500. (Pubitemid 29159018)
30. Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL, and Cheng AJ (2003). Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 89, 681-686. (Pubitemid 37076173)
31. Wahl MI and Carpenter G (1987). Role of growth factors and their receptors in the control of normal cell proliferation and cancer. Clin Physiol Biochem 5, 130-139.
32. Perez-Soler R, Donato NJ, Shin DM, Rosenblum MG, Zhang HZ, Tornos C, Brewer H, Chan JC, Lee JS, Hong WK, et al. (1994). Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852. J Clin Oncol 12, 730-739. (Pubitemid 24110912)
33. Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, and Nexo E (1995). A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 72, 1487-1493. (Pubitemid 26002661)
34. Ishitoya J, Toriyama M, Oguchi N, Kitamura K, Ohshima M, Asano K, and Yamamoto T (1989). Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 59, 559-562. (Pubitemid 19111746)
35. Kawamoto T, Takahashi K, Nishi M, Kimura T, Matsumura T, and Taniguchi S (1991). Quantitative assay of epidermal growth factor receptor in human squamous cell carcinomas of the oral region by an avidin-biotin method. Jpn J Cancer Res 82, 403-410.
36. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, and Demard F (1991). Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13, 132-139.
37. Scambia G, Panici PB, Battaglia F, Ferrandina G, Almadori G, Paludetti G, Maurizi M, and Mancuso S (1991). Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer 67, 1347-1351.
38. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, and Milas L (2002). Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62, 7350-7356. (Pubitemid 36025259)
39. Sokolov K, Galvan J, Myakov A, Lacy A, Lotan R, and Richards-Kortum R (2002). Realistic three-dimensional epithelial tissue phantoms for biomedical optics. J Biomed Opt 7, 148-156. (Pubitemid 34278422)
40. De Rosa FS, Marchetti JM, Thomazini JA, Tedesco AC, and Bentley MV (2000). A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release 65, 359-366. (Pubitemid 30122938)
41. Kurihara-Bergstrom T, Flynn GL, and Higuchi WI (1987). Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: dimethyl sulfoxide mediation of vidarabine (ara-A) permeation of hairless mouse skin. J Invest Dermatol 89, 274-280. (Pubitemid 17126580)
42. Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar AK, Williams MD, Kurachi C, and Gillenwater AM (2008). Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt 13, 024019.
43. Muller MG, Valdez TA, Georgakoudi I, Backman V, Fuentes C, Kabani S, Laver N, Wang Z, Boone CW, Dasari RR, et al. (2003). Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer 97, 1681-1692. (Pubitemid 36350711)
44. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, and Gillenwater A (2008). Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res 14, 2396-2404.
45. Lee SH, Lee S, Youn YS, Na DH, Chae SY, Byun Y, and Lee KC (2005). Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1. Bioconjug Chem 16, 377-382. (Pubitemid 40388214)
46. Powell MF, Grey H, Gaeta F, Sette A, and Colon S (1992). Peptide stability in drug development: a comparison of peptide reactivity in different biological media. J Pharm Sci 81, 731-735. (Pubitemid 23006807)
47. Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, Hirschi K, Mawad ME, Barry MA, and Sevick-Muraca EM (2007). Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt 12, 024017. (Pubitemid 46930498)
48. Li K, Thomasson D, Ketai L, Contag C, Pomper M, Wright M, and Bray M (2005). Potential applications of conventional and molecular imaging to biodefense research. Clin Infect Dis 40, 1471-1480. (Pubitemid 40628636)
49. Nakamura T, Takasugi H, Aizawa T, Yoshida M, Mizuguchi M, Mori Y, Shinoda H, Hayakawa Y, and Kawano K (2005). Peptide mimics of epidermal growth factor (EGF) with antagonistic activity. J Biotechnol 116, 211-219. (Pubitemid 40221849)